Abeona Therapeutics Inc vs Invesco Galaxy Bitcoin ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Invesco Galaxy Bitcoin ETF trades at $63.04. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | BTCO | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Crypto-linked |
52-Week High | $7.45 | $125.14 |
52-Week Low | $4.17 | $58.40 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.
Read more on BTCO →